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Abstract 
Purpose: To evaluate the effects of Citrus aurantifolia and Cinnamomum burmannii extracts (Jermanis) 
on the number of pancreatic β-cells and levels of superoxide dismutase (SOD), low-density lipoprotein 
(LDL), and transforming growth factor-beta (TGF-β)  in β-cells. 
Methods: Various doses of a combination of extracts of C. aurantifolia and C. burmannii were given 
orally to 25 male Wistar rats (Rattus norvegicus) every 2 h for 30 days. Doses of 100, 300 and 500 
mg/kg/day C. aurantifolia extract were considered low, medium and high doses, respectively, while, 
200, 400 and 800 mg/kg/day C. burmannii extract were considered low, medium and high doses, 
respectively. LDL and SOD levels in blood serum were analyzed spectrophotometrically. TGF-β 
expression was evaluated by immunohistochemistry. Pancreatic tissue sections (diameter of a β-cell) 
were evaluated by light microscopy after hematoxylin and eosin staining. 
Results: The combination of C. aurantifolia and C. burmannii extracts increased SOD levels, TGF-β 
expression and the number of β-cells and decreased LDL levels in hyperglycemic rats. The results 
indicate that the highest doses of C. aurantifolia and C. burmannii increased the number of β-cells in the 
islets of Langerhans. The combined extracts of C. aurantifolia and C. burmannii significantly affected 
pancreatic cell regeneration. 
Conclusion: The combination of C. aurantifolia and C. burmannii extracts may be a promising 
alternative preventative medicine for management of diabetic complications in patients with 
hyperglycemia. 
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Diabetes mellitus (DM) is a chronic disease that 
is increasing globally, including Indonesia. DM is 
related to economic status and lifestyle changes 
[1]. The prevalence of DM in urban regions is 
approximately 5.7 % [2,3]. In the United 
Kingdom, DM (all types) is estimated to affect 
approximately 2.4 million people (prevalence of 4 
%), of which 1.4 million (prevalence of 2.5 %) are 
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diagnosed, while 1 million go undiagnosed [4].  
 
If DM is not well controlled, it leads to NAD(P)H 
oxidation, which induces the production of free 
radicals [5]. Excessive production of free radicals 
can trigger oxidative stress, which can damage 
lipids and thereby increase the level of low-
density lipoprotein (LDL) in the blood [6]. Free 
radicals can damage the smooth muscle cells of 
blood vessels, which are a source of superoxide 
dismutase (SOD) [7]. 
 
As the effects of free radicals in DM can lead to 
complications, additional antioxidants are 
required. Citrus aurantifolia and Cinnamomum 
burmannii contain flavonoids with antioxidant 
properties and have a strong protective effect 
against radiation exposure [8,9]. One of the 
growth factors involved in pancreatic 
organogenesis is transforming growth factor-beta 
(TGF-β) [10-12]. 
 
In this study, hyperglycemic rats were fed a high-
cholesterol diet and treated with a combination of 
extracts from C. aurantifolia and C. burmannii, 
which have antioxidant activity. The effect of the 
extract treatment on the complications caused by 
hyperglycemia and the high-cholesterol diet were 
assessed. A previous study showed that 
flavonoid antioxidants derived from green tea 
decreased cholesterol, glucose and triglyceride 
levels in rats on a high-fat diet [13]. Therefore, 
the aim of this study was to evaluate the effect of 
a combination C. aurantifolia and C. burmannii 
extracts on SOD and LDL levels, TGF-β 
expression and the number of β-cells in the islets 
of Langerhans in a hyperglycemic rat model. Our 
results showed that a combination of C. 
aurantifolia and C. burmannii extracts is a 





Preparation of rats 
 
Twenty-five male rats (Rattus novergicus) were 
acclimatized under laboratory conditions for 1 
week with adequate feeding. On the last day, 
fasting blood glucose levels were measured, and 
the rats with normal blood sugar levels (90 – 110 
mg/dl) were selected. The rats were 
intraperitoneally injected with streptozotocin at 30 
mg/kg body weight (BW). A week after 
streptozotocin induction, blood glucose levels 
were measured after fasting for 6 hours. Rats 
with a sugar level > 250 mg/dl (using a blood 
glucose meter) were considered hyperglycemic. 
The Ethics Committee of Polytechnic of Health, 
The Ministry of Health in Malang approved this 
study (approval ref no. 100/KEPK-
POLKESMA/2015). The experimental proce-
dures were performed according to the principles 
of the Institute for Laboratory Animal Research in 
the Guide for the Care and Use of Laboratory 
Animals [14]. 
 
Preparation of Citrus aurantifolia and 
Cinnamomum burmannii extracts 
 
C. aurantifolia juice was filtered using flannelette 
and then dried using a freeze dryer. C. burmannii 
was powdered using size 40 mesh. Then, 1 kg C. 
burmannii powder was dissolved in 7 l 95% 
ethanol, with occasional stirring for 24 hours, and 
then filtered. The filtrate was collected, and the 
precipitate was macerated for 24 hours, and re-
maceration was conducted for 2–5 days. The 
collected filtrate was evaporated at 60˚C until it 
turned into a thick liquid. This thick liquid was 




Rats were divided into five treatment groups: (1) 
negative control, standard diet (G1); (2) positive 
control, high-cholesterol diet (G2); (3) high-
cholesterol diet + C. aurantifolia 100 mg/kg/day 
and C. burmannii 200 mg/kg/day (G3); (4) high-
cholesterol diet + C. aurantifolia 300 mg/kg/day 
and C. burmannii 400 mg/kg/day (G4); and (5) 
high-cholesterol diet + C. aurantifolia 500 
mg/kg/day and C. burmannii 800 mg/kg/day 
(G5). 
 
Prior to treatment, rats were adapted to 
laboratory conditions for 7 days to adjust to the 
environment (e.g., cage changes and feeding 
times) and were fed a standard feed diet during 
this adaptation period. 
 
In groups 3, 4 and 5, a few days after alloxan 
induction, the rat's blood glucose levels were 
examined immediately because the extract was 
given when the blood glucose level was above 
200 mg/dl (5–6 days). The treatment was carried 
out over the course 30 days, then the glucose 
level, LDL, and SOD were examined. 
 
Examination of fasting blood serum LDL (low-
density lipoprotein) level 
 
The blood (~ 3 mL) was collected from rats’ heart 
and then centrifuged at 3000 rpm for 20 minutes. 
Then serum was collected and analyzed. LDL 
measurements were conducted using specific 
colorimetric tests (Horiba ABX Diagnostics, 
Montpellier, France) and an automated analysis 
system (COBAS MIRA, Roche, Basel, 
Switzerland). LDL levels were then measured 
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using ABX PENTRA CP (ABX Pentra, 
Montpellier, France). 
 
Measurement of superoxide dismutase 
content 
 
The blood (~ 3 mL) was centrifuged at 3500 rpm 
for 20 min. The supernatant was collected and 
centrifuged at 6000 rpm for 10 minutes at 4˚C 
and then transferred to Eppendorf tubes. The 
supernatant was diluted with xanthine, xanthine 
oxidase, nitroblue tetrazolium (NBT), and 
phosphate-buffered saline (PBS). The sample 
was diluted with PBS to a total volume of 3500 
μL and incubated at 30°C for 30 minutes (until 
the sample turned purple). The SOD level was 
measured by UV/Vis spectrophotometry (500 – 
600 nm). 
 
Preparation of pancreatic sections for 
histological examination 
 
The pancreas was solidified in a paraffin block 
and then cut into 5 μm sections using a 
microtome. Sections were dried using a hot plate 
at 38 – 40 °C and then stored in an incubator at 
38 – 40 °C for 24 h. 
 
Evaluation of transforming growth factor-beta 
expression 
 
TGF-β expression was determined using 
immunohistochemical methods. Prepared slides 
were washed with PBS (pH 7.4) and then 3 % 
Hydrogen Peroxide (H2O2) for 20 min. The slides 
were washed again with PBS (pH 7.4) for 5 
minutes (three times). The slides were blocked 
with 5 % fetal bovine serum for 1 hour and then 
washed with PBS (pH 7.4) for 5 min (three 
times). The prepared slides were incubated with 
primary anti-rat TGF-β antibody [antibodies-
online GmbH, Schloss-Rahe-Str. 15, 52072 
Aachen, Germany] overnight at 4 °C and then 
washed with PBS (pH 7.4) for 5 min (three 
times). 
 
The slides were incubated with a secondary anti-
biotin antibody (Santa Cruz Biotechnology, USA) 
for 1 h at room temperature, washed with PBS 
(pH 7.4) for 5 min (three times) and incubated 
with streptavidin-horseradish peroxidase for 40 
min. The slides were washed with PBS (pH 7.4) 
for 5 minutes (three washes) and then incubated 
for 10 minutes with diaminobenzidine (DAB). 
 
The slides were washed with PBS (pH 7.4) for 5 
min (three washes). Counterstaining was 
performed using Mayer’s hematoxylin for 10 min. 
The slides were washed and dried in Entellan 
mounting medium and covered with a cover 
glass. Positive TGF-β expression was indicated 
by a brown staining color. The percentage of 
cells positive for TGF-β expression was 
calculated using Axiovision software. 
 
Pancreatic tissue repair evaluation using 
hematoxylin and eosin staining 
 
For hematoxylin and eosin staining, tissues were 
first deparaffinized and then placed in storied 
xylol for 5 minutes. During the rehydration stage, 
the prepared tissues were placed in a graded 
ethanol series (95, 90, 80 and 70 %) for 5 min 
and then soaked in distilled water for 5 min. 
Hematoxylin was added for 10 minutes until the 
sections showed strong staining. The tissues 
were washed with water for 30 min and then 
rinsed with distilled water before staining with 
eosin for 5 min. Then, dehydration was 
performed by subjecting the tissues to a series of 
ethanol washes consisting of 80, 90, 95 % and 
absolute ethanol. The tissues were cleared by 
placing in 1,2 xylol and were then dried and 




Data were analyzed using the Statistical 
Package for the Social Sciences (SPSS) version 
1.9. The data were assessed for normal 
distribution and variance, and differences 
between groups were determined by one-way 
ANOVA with Tukey’s test. Differences between 




The results showed that the extracts of C. 
aurantifolia and C. burmannii had a significant 
effect on blood glucose levels (p = 0.035) (Figure 
1). There was no difference between the 
negative control group (G1) and the G4 group 
that consumed C. aurantifolia (300 mg/kg/day) 
and C. burmannii (400 mg/kg/day). The C. 
aurantifolia and C. burmannii extracts lowered 
the glucose level by 53.2 %. The decrease in 
glucose levels in the other groups were not 
significant. 
 
The C. aurantifolia and C. burmannii extracts 
also had a significant effect on SOD levels in the 
blood (p = 0.00). There was a significant 
difference between the negative control group 
(K1) and the groups K3, K4 and K5. However, 
there was no significant difference between the 
groups that were treated with the extracts of C. 
aurantifolia and C. burmannii. The results 
showed that the highest increase in SOD level 
occurred when the dose of C. aurantifolia was 
300 mg/kg/day and the dose of C. burmannii was 
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400 mg/kg/day. The extracts of C. aurantifolia 
and C. burmannii was able to increase the SOD 
level by 75.86 % in group K4, 73.4 % in group K3 
and 66.9 % in group K5 (Figure 2). 
 
 
Figure 1: Effect of the extract of C. aurantifolia and C. 
burmannii on blood glucose levels in fasting Wistar 
rats after treatment. 
 
 
Figure 2 Effect of the combined extract of C. 
aurantifolia and C. burmannii on SOD levels (mg/mL) 
in fasting Wistar rats after treatment 
 
The LDL levels (Figure 3) showed that the 
extracts of C. aurantifolia and C. burmannii had a 
significant effect on cholesterol levels (p = 0.00). 
There were significant differences among the 
negative control (G1), G2, G3, G4 and G5 
groups, with the lowest LDL levels found in the 
G1 and G5 groups (treated with 500 and 800 




Figure 3: Low-density lipoprotein blood levels (mg/dl) 
in fasting Wistar rats after treatment 
 
Neogenesis was analyzed by quantifying the 
number of β-cells. TGF-β levels and the number 
of β-cells in the islets of Langerhans were 
correlated with the dose of C. aurantifolia and C. 
burmannii extracts. The highest doses of the 
extracts increased the number of β-cells 
significantly (Figure 4a). In addition, to confirm 
the effect of the extract, TGF-β expression was 
evaluated as an indicator of improvement. The 
results showed that treatment with the C. 
aurantifolia and C. burmannii extracts increased 
the expression of TGF-β (Figure 4b). β-Cell 
death in diabetic patients triggers the expression 
of several cytokines, such as IL-1β, TNF-α, IFN-β 
and IFN-γ. Administration of the C. aurantifolia 
and C. burmannii extracts prevented β-cell 
death. β-cell regeneration is a self-renewal 






Figure 4: Effect of the extract of C. aurantifolia and C. 





The results showed that extracts of C. 
aurantifolia and C. burmannii had a significant 
effect on blood glucose and SOD levels. The 
extracts lowered the glucose level by 53.2%, and 
the 300 mg/kg BW/day C. aurantifolia and 400 
mg/kg BW/day C. burmannii doses increased the 
SOD level. The antioxidant defense system 
stimulates the cellular repair response in the 
presence of oxidative stress [16]. SOD plays an 
important role in protecting cells from oxidative 
stress. Oxidative stress is initiated by an increase 
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in the production of free radicals. Auto-oxidation 
of glucose can decrease the concentration of 
low-molecular-weight antioxidants in tissue and 
disrupt the enzymatic activity of antioxidant 
defenses [17]. In DM patients, a decrease in the 
SOD level is related to production of various 
markers of oxidative stress, such as lipid 
hydroperoxide, conjugated dienes and protein 
carbonyl [18]. C. aurantifolia contains high levels 
of antioxidants.  Evaluation of SOD activity in 140 
types of plants showed very high SOD activity in 
C. aurantifolia and C. burmannii [19]. 
 
C. aurantifolia contains chemical compounds 
such as citric acid, essential oils (citral, limonene, 
felandren, C. aurantifolia camphor, kadinen, 
geranilasetat, linalilasetat, aktilaldehid and 
nonildehid), vitamin C and flavonoids (hesperidin, 
hesperetin 7-rutinoside, tangeretin, naringin, 
eriocitrin and eriocitrocide) [20]. Vitamin C 
(ascorbic acid) is an inhibitor of the enzyme 
aldose reductase.  
 
Another benefit of antioxidants is that they 
minimize the formation of advanced glycation 
end products (AGEs) in the polyol pathway 
(sorbitol–aldose reductase pathway). A reduction 
in tissue accumulation of sorbitol would suppress 
fructose synthesis; thus, the process of non-
enzymatic glycosylation would also be 
suppressed. Ascorbic acid works extracellularly 
in blood vessels and intracellularly in endothelial 
cells. Extracellularly, this antioxidant suppresses 
formation of superoxide radicals, which are 
formed during the glucose auto-oxidation 
process [21]. Some citrus species such as C. 
aurantifolia, Citrus aurantium, Citrus sinensis and 
Citrus grandis have been confirmed to have anti-
diabetic properties [22]. The flavonoids in C. 
aurantifolia juice were found to reduce oxidative 
stress in diabetic rats [23]. 
 
Hyperglycemic conditions increase the oxidation 
of NAD(P)H, which induces the production of free 
radicals. Excessive free radical production 
triggers oxidative stress and damages blood 
vessels [6]. Under these conditions, the smooth 
muscle cells of blood vessel walls become 
damaged, leading to decreased SOD production 
[7]. C. burmannii is also capable of decreasing 
blood glucose levels [24]. C. burmannii contains 
methylhydroxychalcone polymer (MHCP) and 
other substances that increase the uptake of 
glucose and insulin receptor phosphorylation 
[23]. 
 
The analysis of LDL levels showed that the 
extracts of C. aurantifolia and C. burmannii had a 
significant effect on cholesterol levels. Lime 
extract contains citric acid, which can lower the 
pH in the digestive tract. Acidic conditions in the 
gastrointestinal tract stimulate the formation of 
bile salts to neutralize the acid. Bile salts are the 
end product of cholesterol metabolism. Under 
acidic conditions in the digestive system, more 
cholesterol is metabolized, and the blood 
cholesterol level decreases [25]. Khan et al [24] 
also found that C. aurantifolia lowered LDL levels 
in blood. In the treatment group K5, the acidic 
conditions in the digestive tract stimulated the 
pancreas to increase the production of liquid 
sodium bicarbonate formed from cholesterol, 
leading to a decrease in the blood cholesterol 
level. The blood cholesterol showed a direct 
relationship with the LDL level (the higher the 
blood cholesterol level, the higher the level of 
LDL and vice versa).  
 
Compared with the control group (K1), higher 
LDL cholesterol levels were observed in rats with 
DM that did not receive extract treatment (K2 
group). This was due to the high-fat diet given to 
K2 rats to induce hyperglycemia (DM), which 
also increased the LDL level. Furthermore, DM 
patients also suffer from dyslipidemia [23], 
because DM is associated with altered HDL 
cholesterol levels due to HDL catabolism. 
Increased HDL catabolism occurs due to an 
increase in hepatic lipase activity in liver cells. 
Glucose levels can be used as an indicator of 
increased hepatic lipase activity. An increase in 
glucose levels can occur as a result of insulin 
resistance [22]. 
 
C. aurantifolia contains flavonoid compounds 
such as naringin and hesperidin, which can 
increase the extent of hyperlipidemia in animals 
with type 2 DM by regulating fatty acid and 
cholesterol metabolism. C. aurantifolia extract 
also affects the expression of genes encoding 
enzymes involved in glucose metabolism [20]. 
 
C. burmannii contains MHCP, an active 
compound that acts as an insulin mimic. The 
mechanisms affected by MHCP include insulin 
receptor phosphorylation, glucose uptake and 
glycogen synthesis [22]. In DM patients, MHCP 
may decrease insulin resistance, which in turn 
can help control the release of non-esterified 
fatty acids from adipose tissue and increase the 





The combination of C. aurantifolia and C. 
burmannii extracts may be a promising 
alternative preventative medicine for 
management of diabetic complications in patients 
with hyperglycemia. 
Mawarti et al 
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